Literature DB >> 15211174

Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration.

Fina C Barouch1, Joan W Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15211174     DOI: 10.1097/00004397-200404430-00005

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  11 in total

1.  Predictors of 1-year visual outcome in OCT analysis comparing ranibizumab monotherapy versus combination therapy with PDT in exsudative age-related macular degeneration.

Authors:  Birgit Weingessel; Kata Mihaltz; Pia Veronika Vécsei-Marlovits
Journal:  Wien Klin Wochenschr       Date:  2015-03-19       Impact factor: 1.704

2.  One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation.

Authors:  Yukari Shirakata; Chieko Shiragami; Ayana Yamashita; Eri Nitta; Atsushi Fujiwara; Fumio Shiraga
Journal:  Jpn J Ophthalmol       Date:  2012-09-19       Impact factor: 2.447

3.  Blockade of the sonic hedgehog signalling pathway inhibits choroidal neovascularization in a laser-induced rat model.

Authors:  Hua He; Hong Zhang; Bin Li; Guigang Li; Zhitao Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

Review 4.  Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities.

Authors:  Chelsea C Estrada; Alejandro Maldonado; Sandeep K Mallipattu
Journal:  J Am Soc Nephrol       Date:  2019-01-14       Impact factor: 10.121

5.  The significance of early treatment of exudative age-related macular degeneration: 12 months' results.

Authors:  Birgit Weingessel; Gregor Hintermayer; Saskia M Maca; Renate Rauch; Pia Veronika Vecsei-Marlovits
Journal:  Wien Klin Wochenschr       Date:  2012-10-24       Impact factor: 1.704

Review 6.  Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration.

Authors:  S S Vedula; M G Krzystolik
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

7.  Receptor tyrosine kinase inhibitors AG013764 and AG013711 reduce choroidal neovascularization in rat eye.

Authors:  F E Wang; G Shi; M R Niesman; D A Rewolinski; S S Miller
Journal:  Exp Eye Res       Date:  2007-02-11       Impact factor: 3.467

Review 8.  Ranibizumab.

Authors:  Stephanie K A Blick; Gillian M Keating; Antona J Wagstaff
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1α in a mouse model of closed eye contact lens wear.

Authors:  Peng Chen; Hongmei Yin; Ye Wang; Yao Wang; Lixin Xie
Journal:  Mol Vis       Date:  2012-04-06       Impact factor: 2.367

Review 10.  Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration.

Authors:  Ramasamy Kim
Journal:  Indian J Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.